Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation

详细信息	查看全文 | 推荐本文 |

• 作者：Yoshino Matsuo ; Shin-ichiro Miura ; Akira Kawamura ; Yoshinari Uehara ; Kerry-Anne Rye ; Keijiro Saku
• 关键词：Reconstituted high density lipoprotein ; Sphingosine-1-phosphate ; Tube formation ; Extracellular-signal-regulated kinases
• 刊名：Atherosclerosis
• 出版年：2007
• 期刊代码：28_00219150
• 类别：med
• 出版时间：September 2007
• 卷：194
• 期：1
• 页码：159-168
• 文件大小：1494 K

摘要

Reconstituted high-density lipoprotein (rHDL) has been shown to produce a rapid regression of atherosclerosis in animal models and humans. Sphingosine-1-phosphate (S1P), which is a bioactive lipid in HDL, plays a role in mitogenesis, endothelial cell motility, and cell survival, as well as organization and differentiation into a vessel. In this study, we examined the direct role of a newly developed rHDL, [POPC(1-palmitoyl-2-oleoyl phosphatidylcholine)/S1P/apolipoproteinA–I(A–I)]rHDL containing S1P in tube formation in endothelial cells (ECs) as well as cholesterol efflux in macrophage. The effect of (POPC/S1P/A–I)rHDL on cholesterol efflux in macrophage was similar to that of conventional rHDL, (POPC/A–I)rHDL. In addition, (POPC/S1P/A–I)rHDL induced EC proliferation through the activation of phospho-Akt and phospho-extracellular-signal-regulated kinases (p-ERK) 1/2 and EC tube formation, and this effect was blocked by inhibitors of Akt, ERK and endothelial nitric-oxide synthase (eNOS). In addition, (POPC/S1P/A–I)rHDL-induced p-ERK1/2 activation and EC tube formation can be mainly attributed to S1P-stimutated signaling through S1P₂ and S1P₃ as determined by an anti-sense strategy. In conclusion, (POPC/S1P/A–I)rHDL induces cholesterol efflux independently of S1P but has additional S1P-mediated effects on EC tube formation mediated by Akt/ERK/NO through S1P₂ and S1P₃. In the future, these new discs may be useful for the treatment of atherosclerotic and ischemic cardiovascular disease, such as acute coronary syndrome and atherosclerosis obliterans.